Comparison between generalized retinal arteriolar narrowing and left ventricular mass in young untreated hypertensive

Andrea Grosso1, Franco Rabbia, Antonio Fea

  • 1Department of Physiopathology, Section of Ophthalmology University of Turin, Italy. 78andrea1@tin.it

Blood Pressure
|March 27, 2007
PubMed

Insights

This study found no significant link between retinal arteriolar narrowing and left ventricular hypertrophy in hypertensive patients. Further research is needed to understand early microvascular changes and hypertensive organ damage.

Area of Science:

  • Cardiology
  • Ophthalmology
  • Hypertension Research

Background:

  • Hypertension can lead to organ damage, including cardiac and microvascular changes.
  • Retinal microvascular changes may serve as an indicator of systemic vascular health.
  • Left ventricular hypertrophy is a common consequence of sustained hypertension.

Purpose of the Study:

  • To investigate the association between retinal arteriolar narrowing and left ventricular hypertrophy in patients with hypertension.
  • To determine if arteriole-to-venule ratio (AVR) correlates with left ventricular mass in hypertensive individuals.

Main Methods:

  • Thirty hypertensive patients were assessed for generalized retinal arteriolar narrowing using computer-scanned retinal photographs (AVR).
  • Left ventricular hypertrophy was evaluated using quantitative M-mode echocardiography.
  • Patients were stratified according to 2003 European Society of Hypertension guidelines.

Main Results:

  • Left ventricular hypertrophy was identified in 33% of the patients.
  • No statistically significant correlation was found between the arteriole-to-venule ratio (AVR) and left ventricular mass (Spearman r = 0.22; p = 0.23).
  • Retinal vessel diameters did not significantly differ between hypertension grades 1 and 2.

Conclusions:

  • The study did not establish a correlation between retinal arteriolar narrowing (AVR) and left ventricular mass in this hypertensive cohort.
  • Further clinical studies are necessary to explore the relationship between early microvascular alterations and other indicators of hypertensive organ damage.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...